Impact of drug-eluting stents on transferring treatment with coronary surgical revascularization among patients initially admitted to department of internal medicine

National Medical Journal of China

Volumn 87, Issue 22, 2007, Pages 1518-1522

  He, Li Qun ^a   Ma, Chang Sheng ^a   Nie, Shao Ping ^a   Lü, Qiang ^a   Jia, Chang Qi ^a   Du, Xin ^a   Liu, Xiao Hui ^a   Dong, Jian Zeng ^a   Li, Zhi Zong ^a   Chen, Fang ^a   Zhou, Yu Jie ^a   Lü, Shu Zheng ^a   Wu, Xue Si ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Drug eluting stents; Myocardial revascularization; Transferring treatment

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PREDICTION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNAL MEDICINE; MALE; MIDDLE AGED; PATIENT TRANSFER;

EID: 34548253924     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutancous coronary intervention: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). Circulation, 2001, 103: 3019-3041.
2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003, 349: 1315-1323.
3. Chinese source.
4. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee on Coronary Angiography). J Am Coll Cardiol, 1999, 33: 1756-1824.
5. Cannon CP, Battler A, Brindis RG, et al. ACC key elements and data definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: a report of the American College of Cardiology Task Force on Clinical Data Standards(acute coronary syndromes writing committee). J Am Coll Cardiol, 2001, 38: 2114-2130.
6. Reeves BC, Angelini GD, Bryan AJ, et al. A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery. Health Technol Assess, 2004, 8: 1-43.
7. Ellis SG, Guetta V, Miller D, et al. Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era an analysis of results from 10907 lesions and proposal for new classification scheme. Circulation, 1999, 100: 19712-19716.
8. Liddicoat JR, Torre RD, Ho KK, et al. Initial impact of drug-eluting stents on coronary artery bypass graft surgery. Ann Thorac Surg, 2006,81:1239-1242.
9. Kobayashi Y, de Gregorio J, Kobayashi N, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol, 1999;34:651-659.
10. Schofer J, Schlüter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (ESIRIUS). Lancet, 2003, 362:1093-1099.
11. Schampaert E, Cohen EA, Schlüter M, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries(C-SIRIUS). J Am Coll Cardiol, 2004,43:1110-1115.
12. Degertekin M, Arampatzis CA, Lemos PA, et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol, 2004, 93:826-829.
13. Silber S, Albertason P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J, 2005, 26: 8042-8047.
14. Valgimigli M, van Mieghem CA, Ong AT, et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the rapamycin-eluting and taxus stent evaluated at Rotterdam cardiology hospital registries (RESEARCH and T-SEARCH). Circulation, 2005,111:1383-1389.
15. Nakamura S, Muthusamy TS, Bae JH, et al. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions. Am J Cardiol, 2005,95: 161-166.
16. Ong AT, Serruys PW. Drug-eluting stents. Tex Heart Inst J, 2005, 32:372-377.
17. Serruys PW. Preliminary results of the second Arterial revascularization therapy study trial(ARTS II), presented at the American College of Cardiology annual scientific sessions, March 6, 2005, Orlando, Florida.
18. Saia F, Marzocchi A, Serruys PW. Drug-eluting stents. The third revolution in percutaneous coronary intervention. Ital Heart J, 2005,6:289-303.